Skip to main content
Clinical Trials/ACTRN12618000931279
ACTRN12618000931279
Recruiting
未知

Assessing Predictive and Prognostic Biomarkers in Germ Cell Tumours - Testis

Walter and Eliza Hall Institute for Medical Research0 sites800 target enrollmentJune 1, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Germ Cell Tumour (GCT)
Sponsor
Walter and Eliza Hall Institute for Medical Research
Enrollment
800
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2018
End Date
TBD
Last Updated
3 years ago
Study Type
Observational
Sex
Male

Investigators

Sponsor
Walter and Eliza Hall Institute for Medical Research

Eligibility Criteria

Inclusion Criteria

  • Histologically or cytologically confirmed GCT (non\-seminoma or seminoma); or exceptionally raised tumour markers (AFP greater than or equal to 1000ng/mL and/or HCG greater than or equal to 5000 IU/L) without histologic or cytologic confirmation in the rare case where pattern of metastases consistent with GCT, high tumour burden, and a need to start therapy urgently.
  • Primary arising in testis, retro\-peritoneum, or mediastinum.
  • Able to be accessible for follow\-up and data collection.
  • Written, voluntary and informed consent.
  • Able to undergo collection of blood specimens.

Exclusion Criteria

  • No archival tissue specimen available.
  • Patient not accessible for follow up and data collection.

Outcomes

Primary Outcomes

Not specified

Similar Trials